Octreotide Injection

Category: Somatostatin analogue / Hormonal therapy
Form: Injectable solution for subcutaneous (SC) or intravenous (IV) administration

Uses:

• Acromegaly: reduces excess growth hormone production.

• Neuroendocrine tumors (e.g., carcinoid tumors, VIPomas): controls hormone-related symptoms like flushing and diarrhea.

• Gastrointestinal bleeding: particularly from esophageal varices, by reducing portal hypertension.

• Other uses: may be used in certain cases of pancreatic hormone-secreting tumors.

Mechanism of Action:

• Octreotide mimics somatostatin, a natural hormone that inhibits several endocrine and exocrine functions.

• Reduces secretion of growth hormone, insulin, glucagon, and gastrointestinal hormones.

• Causes vasoconstriction in the splanchnic circulation, which helps control bleeding from varices.

• Reduces tumor-related hormone hypersecretion and associated symptoms.

Administration:

• Can be given as a subcutaneous injection, usually multiple times a day, or as a slow intravenous infusion in acute situations.

• Dosage depends on condition, severity, and patient response.

• Long-acting formulations (octreotide LAR) are available for monthly intramuscular administration in chronic therapy.

Side Effects:

• Gastrointestinal: nausea, vomiting, abdominal pain, diarrhea, or constipation.

• Metabolic: hyperglycemia or hypoglycemia due to effects on insulin and glucagon.

• Cardiovascular: bradycardia, conduction abnormalities.

• Local reactions: pain or irritation at injection site.

• Rarely: gallstones with long-term therapy.

Precautions:

• Monitor blood glucose in diabetic patients.

• Caution in patients with cardiac conduction issues or bradycardia.

• Long-term therapy may require monitoring for gallbladder complications.

Summary:
Octreotide Injection is a synthetic somatostatin analogue used to control hormone secretion in acromegaly, neuroendocrine tumors, and gastrointestinal bleeding. It works by inhibiting multiple hormones and reducing blood flow in the splanchnic circulation. Administration can be subcutaneous or intravenous, with side effects mainly affecting the gastrointestinal system, metabolism, and sometimes cardiac rhythm.